×
Back to Agenda
Session 6: OPDP Research Agenda Update
Session Chair(s)
Catherine Gray, PHARMD
Director, Office of Prescription Drug Promotion, OMP, CDER , FDA, United States
This session is designed to help attendees gain a better understanding of the FDA/OPDP Research program and how it may contribute to guidance and policy development.
Learning Objective : At the conclusion of this session, participants should be able to:Develop and present an elevator pitch- Implement the lessons with actual networking activity
Speaker(s)
Kathryn Aikin, PHD, MS
Senior Social Science Analyst, Research Team Lead, OPDP, CDER, FDA, United States
Panelists:
Kevin Betts, PHD
Social Science Analyst, OPDP, OMP, CDER, FDA, United States
Panelists
Amie O'Donoghue, PHD
Social Science Analyst, OPDP, OMP, CDER, FDA, United States
Panelists
Helen W. Sullivan, PHD, MPH
, United States
Panelist
Have an account?